ImmunoHub.org – Immuno-Oncology Essentials – Home › Forums › Immunotherapy › Reimbursement › Reimbursement for infliximab › Reply To: Reimbursement for infliximab
February 4, 2018 at 2:08 am
#4656
Virginia’s comment made me think about this question: How many others are using vedolizumab for infliximab refractory colitis?